Search the Newsreel

Sarepta Therapeutics (SRPT) Brings In New CEO Severino Is Its R&D Strategy Entering a New Phase?

Sarepta Therapeutics has appointed Michael Severino, an R&D veteran, as its new CEO, combining his role with a seat on the board. This leadership change comes as Sarepta is focusing on the safety data of its drug ELEVIDYS, particularly regarding acute liver injury. Severino's …

CZR|Caesars Entertainment Inc|Price:29.965|Chg%:+0.025

This article provides an analysis of Caesars Entertainment Inc (CZR) stock, noting its current price, market trends, and key financial figures. It highlights that CZR's fundamentals are stable with high growth potential, and its valuation is considered fairly valued. Analyst ratings suggest a "Hold" …

Caesars Entertainment Inc (CZR1) Q1 2026 Earnings Report - Results, Call & Slides

Caesars Entertainment (CZR1) released its Q1 2026 earnings report, missing EPS expectations at -$8.38 versus a consensus of -$4.24, but beating revenue estimates with $50.11 billion. The company reported 3% year-over-year revenue growth, stable adjusted EBITDAR, and strong performance from its Digital segment with …

QuasarEdge Acquisition Corporation Revenue Breakdown – NYSE:QRED

Vysarn Ltd Revenue Breakdown – ASX:VYS

Caesarstone Ltd (CSTE) Cash Flow

This article provides a detailed cash flow statement for Caesarstone Ltd (CSTE), including quarterly and annual data for operating, investing, and financing activities. It breaks down various components such as net income, capital expenditures, and changes in working capital. Additionally, it offers explanations of …

Sarepta names Michael Severino, former Tessera CEO, as new chief executive

Sarepta Therapeutics, known for its Duchenne muscular dystrophy treatments, has appointed Michael Severino, former CEO of Tessera Therapeutics, as its new chief executive. Severino replaces Doug Ingram, who is retiring after nearly a decade. The company has faced scrutiny over the efficacy and safety …

Sarepta Therapeutics Appoints Michael Severino as CEO

Sarepta Therapeutics has appointed Michael Severino as its new CEO and a Class I director, effective July 28, 2026. Severino replaces Doug Ingram, who is retiring but will remain an adviser for the rest of 2026. Severino's three-year contract includes a $1.18 million base …

Samsara EVP, CTO John Bicket sells $9.5m in stock in July

Samsara Inc.'s EVP, CTO, and Director John Bicket sold 262,900 shares of Class A Common Stock for approximately $9.5 million on July 21 and 22, 2026, under Rule 10b5-1 trading plans. These sales occurred during a challenging week for the stock, which declined nearly …

Sarepta Therapeutics Names Michael Severino As CEO; Shares Rise In Pre-Market

(RTTNews) - Sarepta Therapeutics, Inc. (SRPT), a company focused on genetic medicine for rare diseases, has appointed Michael Severino, M.D., as chief executive officer, effective July 28, 2026. Severino will also join the company's Board of Directors, succeeding Doug Ingram, who is retiring and …

LENSAR Inc (LNSR) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of LENSAR Inc (LNSR), listing major shareholders by proportion and categorizing shareholder types. It also provides a historical overview of institutional shareholding data from 2023Q4 to 2026Q1, showing the number of institutions, shares held, and changes over time. …

Sarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEO

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Sarepta Therapeutics has found the leader it hopes can engineer a desperately needed turnaround. The company on Monday announced that Michael Severino, …

Caesarstone Ltd (CSTE) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis for Caesarstone Ltd (CSTE), noting its current valuation score of 9.28, which ranks 9 out of 54 in its industry. It highlights the company's P/E ratio of -0.52 and mentions that relevant data for P/B, P/S, and P/CF …

Saraswati Saree Depot Share Price Forecast to 2030

Zensar Technologies Q1 Results: Earnings call set for July 30

What To Expect From Caesars Entertainment’s (CZR) Q2 Earnings

Asara Resources Issues 13 Million Performance Rights Under Employee Incentive Scheme

Fertitta Entertainment Talks Caesars Integration Prior to 2027 Deal

Fertitta Entertainment is developing plans to integrate its operations with Caesars Entertainment in anticipation of a proposed takeover expected to close in 2027. The strategy involves maintaining Caesars' current management, expanding the Caesars Rewards program, adopting Caesars' compliance systems, and preserving employee jobs and …

Caesarstone Ltd (CSTE) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Caesarstone Ltd (CSTE), listing its major shareholders and their respective proportions. It also provides a breakdown of shareholder types and a historical overview of institutional shareholdings and activity over several quarters.

Caesarstone Ltd (CSTE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Caesarstone Ltd (CSTE), detailing its performance by region. It highlights the company's regional revenue contributions, with the USA being the largest contributor. The data presented focuses on geographical revenue distribution, while business segment data is noted as …

CSTE|Caesarstone Ltd|Price:2.090|Chg%:-0.110

Caesarstone Ltd. (CSTE) is an Israel-based manufacturer of engineered quartz surfaces, primarily used for kitchen countertops and other interior applications. The company offers a wide range of designs and colors across several collections, selling its products under the Caesarstone brand. The article also provides …

Caesars Entertainment Inc (CZR) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Caesars Entertainment Inc (CZR), listing its major institutional holders and their respective proportions. It also categorizes shareholder types and provides a historical view of institutional shareholdings and recent changes in holdings by top investors. Additionally, the article …

LENSAR Inc (LNSR) Cash Flow

This article provides an in-depth look at LENSAR Inc.'s cash flow statements, including operating, investing, and financing activities, across various fiscal quarters. It presents detailed financial data, highlighting changes in cash flows and net income. Additionally, the article includes a Q&A section explaining key …

QRED|QuasarEdge Acquisition Units|Price:10.000|

This article provides a detailed profile of QuasarEdge Acquisition Units (QRED), a blank check company formed for business combinations. It outlines the company's background, financial data, and lists its executive team and independent directors, including Ms. Qi Gong as Chairman, CEO, and CFO. The …

Caesars Entertainment stock holds focus on earnings and debt

Caesars Entertainment's stock performance is heavily influenced by its earnings report, particularly revenue growth, EBITDA, and net leverage, along with its significant debt burden. The company's business model, which integrates physical casinos with growing digital betting operations and a strong loyalty program like Caesars …

Cooper Creek Partners Management LLC Has $22.82 Million Stock Holdings in Caesars Entertainment, Inc. $CZR

Cooper Creek Partners Management LLC significantly reduced its stake in Caesars Entertainment, Inc. (NASDAQ:CZR) by 72.8% in the first quarter, now holding 863,331 shares valued at $22.82 million. Despite this reduction, other institutional investors like AQR Capital Management LLC, MIRAE ASSET GLOBAL ETFS HOLDINGS …

Saregama India posts 13% EBITDA growth in FY26 on cost control

Pansari Developers Ltd. Revenue Breakdown – NSE:PANSARI

LENSAR receives certification for new adaptive cataract treatment system

LENSAR, Inc. has received EU Medical Device Regulation (MDR) certification for its ALLY Adaptive Cataract Treatment System, enabling its commercialization in the European Union. This system is the first cataract laser to use artificial intelligence for iris registration and astigmatism management, aiming to improve …

Samsara, Inc. Class A (IOT) Q2 2025 Earnings Report - Results, Call & Slides

Samsara, Inc. Class A (IOT) reported its Q2 2025 earnings, significantly beating analyst expectations with an actual EPS of $0.88 against a consensus of $0.16, and revenue of $5.26 billion compared to an expected $5.07 billion. The company achieved a year-over-year revenue growth of …

LENSAR Inc (LNSR) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of LENSAR Inc (LNSR)'s dividend and stock split history. It states that the company has distributed $0.00 in dividends over the past five years and shows "No Data" for specific dividend dates. The article includes current stock trading information …

Caesars Entertainment, Inc. Revenue Breakdown – BX:CZR

This article provides a revenue breakdown for Caesars Entertainment, Inc. (BX:CZR). It details the company's financial performance last year, highlighting revenue generated from its "Regional" segment and its primary market, the United States.

SRPT|Sarepta Therapeutics Inc|Price:15.680|Chg%:-0.200

Sarepta Therapeutics Inc (SRPT) is a commercial-stage biopharmaceutical company focusing on RNA-targeted therapeutics and gene therapy for rare diseases like Duchenne muscular dystrophy. The company's fundamentals are considered healthy with high growth potential, and it is currently regarded as fairly valued. Analysts have given …

PT Sarana Menara Nusantara Tbk Revenue Breakdown – IDX:TOWR

Samsara Inc. (IOT) grants 7,801 RSUs to board director Alyssa Henry

Samsara Inc. board director Alyssa Henry received a grant of 7,801 restricted stock units (RSUs) on July 22, 2026. These RSUs will vest in full on the earlier of July 22, 2027, or the day prior to the next annual stockholders meeting, provided she …

Samsara, Inc. Class A Revenue Breakdown – TRADEGATE:YL8

Samsara, Inc. Class A (TRADEGATE:YL8) generated a total revenue of 1.37 billion EUR last year. The majority of this revenue, 1.34 billion EUR, came from its Subscription segment, showing a growth from 1.18 billion EUR in the previous year. The United States was the …